Medical Devices Europe

Europe Carrier Screening Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Europe Carrier Screening Market Industry Trends and Forecast to 2034: Segmented by (Test, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $443.4 Mn Placeholder estimate
Estimate 2025 $487.3 Mn 16.5% of the global market
Projected 2034 $1.14 Bn 133.9% Adds $652.4 Mn over 9 forecast years
CAGR 2025–2034 9.9% Faster than 69% of 173 Medical Devices markets here
Key players 5
  • Europe is 16.48% of the global market.
  • Among regions, the largest is North America at $1.60 Bn.
  • Fastest growing: APAC at 12.5% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$652.4 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Carrier Screening Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $443.4 Mn — —
2025 (base) $487.3 Mn +$43.9 Mn —
2026 (forecast) $535.6 Mn +$48.2 Mn +9.9%
2027 (forecast) $588.6 Mn +$53.0 Mn +20.8%
2028 (forecast) $646.9 Mn +$58.3 Mn +32.7%
2029 (forecast) $710.9 Mn +$64.0 Mn +45.9%
2030 (forecast) $781.3 Mn +$70.4 Mn +60.3%
2031 (forecast) $858.7 Mn +$77.4 Mn +76.2%
2032 (forecast) $943.7 Mn +$85.0 Mn +93.6%
2033 (forecast) $1.04 Bn +$93.4 Mn +112.8%
2034 (forecast) $1.14 Bn +$102.7 Mn +133.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Carrier Screening Market Analysis at a glance
Market size, 2025$487.3 Mn placeholder estimate
Forecast, 2034$1.14 Bn placeholder estimate
Growth (CAGR), 2025–20349.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, condition and end user (see all)
Key playersMyriad Genetics, Inc., Natera, Invitae, Sema4 (GeneDx), Fulgent Genetics (see all)
Regulator in EuropeEU MDRSource: European Commission, medical devices. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Carrier Screening Market Analysis Executive Summary

Carrier screening checks future parents for gene changes they could pass on, such as for cystic fibrosis or spinal muscular atrophy.

Key segments of the carrier Screening market include test (Expanded Panels and Targeted Screening) and condition (Cystic Fibrosis, SMA and Thalassemia).

Bar chart: Europe Carrier Screening market size, 2024–2034, placeholder estimates. $443.4 Mn in 2024, $487.3 Mn in 2025 and $1.14 Bn in 2034, 9.9% CAGR.
Europe Carrier Screening market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Carrier Screening Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the carrier Screening market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the carrier Screening market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the carrier Screening market.

Competitive Landscape for Carrier Screening Market in Europe

The carrier Screening market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Carrier Screening Market in Europe

Carrier Screening in Europe: rules and payment

In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.⁠[1] In the countries we cover here, medical devices are regulated by ANSM (France)⁠[2], BfArM (Germany)⁠[3], Ministry of Health (Italy)⁠[4], Roszdravnadzor (Russia)⁠[5], AEMPS (Spain)⁠[6] and MHRA (UK)⁠[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[8]

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how carrier Screening products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Carrier Screening right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Carrier Screening in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Carrier Screening market in Europe?
Placeholder estimate: about $487.3 Mn in 2025, rising to about $1.14 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Carrier Screening market in Europe growing?
Placeholder estimate: about 9.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Carrier Screening market report cover?
The report splits the market by test (Expanded Panels, Targeted Screening), condition (Cystic Fibrosis, SMA, Thalassemia, Fragile X) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Carrier Screening market?
Key players include Myriad Genetics, Inc., Natera, Invitae, Sema4 (GeneDx) and Fulgent Genetics.
What is driving the Carrier Screening market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the carrier Screening market.
Who regulates Carrier Screening in Europe?
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How much research is published on Carrier Screening?
PubMed lists 837 papers on Carrier Screening added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Europe

See all

Related on genomics and maternal

See the topic